Chordoma is a rare type of primary bone cancer that is typically malignant in nature. This type of tumor occurs mostly at the skull base or along the spine. These tumors are formed from small fragments of embryonic cells that accumulate into the disks of the spinal column. The prevalence is found to be twice in men in comparison with women. Moreover, most of the tumor cases occur between the age group of 50 to 70 years.
According to the American Cancer Society, over 40% of primary ... Read more
Chemotherapy-induced thrombocytopenia (CIT) is a common complication of cancer treatment, characterized by a significant decrease in platelet levels in the blood. This condition can lead to increased bleeding risks and impact patients' ability to undergo chemotherapy as scheduled. This article explores the various therapeutic strategies and advancements in managing chemotherapy-induced thrombocytopenia, with a focus on ensuring patient safety and effective cancer treatment.
Epileptic seizures are a neurological disorder characterized by sudden and unpredictable episodes of abnormal brain activity. These seizures can range from mild to severe and have a significant impact on an individual's quality of life. Fortunately, there are various treatment options available to help manage and control epileptic seizures. This article explores the approaches, medications, and recent advances in the treatment of epileptic seizures.
Acute Kidney Injury (AKI), formerly known as acute renal failure, is a severe medical condition characterized by the abrupt loss of kidney function. It is a critical concern in the healthcare industry, often affecting hospitalized patients, especially those in intensive care units. The Acute Kidney Injury Treatment Market has been growing steadily in recent years, driven by increased awareness, technological advancements, and a rising incidence of AKI cases. This article explores the current ... Read more
The global Lyme Disease Treatment Market is estimated to be valued at US$737.5 million in 2023 and is expected to reach a value of US$XX million by 2023, with a CAGR of 8.4% over the forecast period of 2023 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Lyme disease is an infectious disease caused by the bacteria Borrelia burgdorferi and is ... Read more
Neuroendocrine tumors (NETs) are a group of cancers that begin in the neuroendocrine cells of the body. These rare tumors can develop in tissues and organs that are part of the endocrine (hormone) system such as the lungs, stomach, intestines, pancreas, and liver. For many years, treatment options for NETs were limited. However, in recent times significant progress has been made in developing new targeted therapies and personalized treatment approaches.
